Close Menu

NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Monday that its first quarter 2019 revenues were essentially flat year over year.

For the three months ended March 31, the firm reported revenues of $82.4 million, slightly down from $82.7 million a year ago, and falling short of the consensus Wall Street estimate of $83.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.